The DOI matches its Crossref record; 535 of the 535 references it cites were found in a registry or an index.
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Open accessAbstract
Evidence collectionThe committee systematically collected and reviewed the international and domestic literature published in PubMed, MEDLINE, KoreaMed, and other databases.The literature was limited to research papers published in the English and Korean languages.The keywords used were 'nonalcoholic fatty liver disease,' 'nonalcoholic fatty liver,' 'nonalcoholic steatohepatitis,' 'fatty liver,' 'hepatic steatosis,' and 'steatohepatitis.'In addition, keywords related to specific clinical questions were included. Levels of evidence and grades of recommendationsThe literature gathered for data collection was analyzed in a systematic review, and the quality of evidence was classified based on the modified Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system (Table 1).According to the types of studies, randomized, controlled studies were approached from a high level of evidence, while observational studies were approached from a low level of evidence.Subsequently, the level of evidence basis sets in corresponding stud-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 535
Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy
Idilman, I. S., Aniktar, H., Idilman, R., Kabacam, G., Savas, B., Elhan, A., Celik, A., Bahar, K., & Karcaaltincaba, M. (2013) · Radiology · doi:10.1148/radiol.13121360 · Cited by 389
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385 · cited 22×
“A prospective Korean cohort study of 46,874 men reported that patients with mild and moderate NAFLD (diagnosed by abdominal ultrasound) had a risk of metabolic syndrome 1.5 and 2 times higher, respectively, than the control group.85 In a meta-analysis of Korean studies, the incidence of metabolic syndrome was 40.7% in…”
BackgroundInfluentialSelf-citationAssociation of histologic disease activity with progression of nonalcoholic fatty liver disease
Kleiner, D. E., Brunt, E. M., Wilson, L. A., Behling, C., Guy, C., Contos, M., Cummings, O., Yeh, M., Gill, R., Chalasani, N., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12565 · Cited by 372
Lee, Y., Doumouras, A. G., Yu, J., Brar, K., Banfield, L., Gmora, S., Anvari, M., & Hong, D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.017 · Cited by 371
Lazo, M., Solga, S. F., Horska, A., Bonekamp, S., Diehl, A. M., Brancati, F. L., Wagenknecht, L. E., Pi-Sunyer, F. X., Kahn, S. E., Clark, J. M., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0856 · Cited by 367
Laparoscopic Adjustable Gastric Banding in Severely Obese Adolescents: A Randomized Trial
O’Brien, P. E., Sawyer, S. M., Laurie, C., Brown, W. A., Skinner, S., Veit, F., Paul, E., Burton, P. R., McGrice, M., Anderson, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.81 · Cited by 367
de Lédinghen, V., Vergniol, J., Foucher, J., Merrouche, W., & le Bail, B. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02820.x · Cited by 367
Limanond, P., Raman, S. S., Lassman, C., Sayre, J., Ghobrial, R. M., Busuttil, R. W., Saab, S., & Lu, D. S. K. (2004) · Radiology · doi:10.1148/radiol.2301021176 · Cited by 366
Ratziu, V., Charlotte, F., Bernhardt, C., Giral, P., Halbron, M., LeNaour, G., Hartmann-Heurtier, A., Bruckert, E., & Poynard, T. (2010) · Hepatology · doi:10.1002/hep.23270 · Cited by 366
Fatty Infiltration of Liver in Hyperlipidemic Patients
Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B., & Minuk, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005661516165 · Cited by 360
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 358
Younossi, Z. M., Loomba, R., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander‐Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., et al. (2018) · Hepatology · doi:10.1002/hep.29724 · Cited by 357
Loomba, R., Lim, J. K., Patton, H., & El-Serag, H. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.053 · Cited by 357
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
Zein, C. O., Yerian, L. M., Gogate, P., Lopez, R., Kirwan, J. P., Feldstein, A. E., & McCullough, A. J. (2011) · Hepatology · doi:10.1002/hep.24544 · Cited by 356
NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice
Nobili, V., Marcellini, M., Devito, R., Ciampalini, P., Piemonte, F., Comparcola, D., Sartorelli, M. R., & Angulo, P. (2006) · Hepatology · doi:10.1002/hep.21262 · Cited by 352
Bacchi, E., Negri, C., Targher, G., Faccioli, N., Lanza, M., Zoppini, G., Zanolin, E., Schena, F., Bonora, E., & Moghetti, P. (2013) · Hepatology · doi:10.1002/hep.26393 · Cited by 350
Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography
Yoneda, M., Suzuki, K., Kato, S., Fujita, K., Nozaki, Y., Hosono, K., Saito, S., & Nakajima, A. (2010) · Radiology · doi:10.1148/radiol.10091662 · Cited by 348
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, A. W.-H., Chermak, F., Choi, P. C.-L., Merrouche, W., Chu, S. H.-T., Pesque, S., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.331 · Cited by 345
Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes
Lipscombe, L. L., Gomes, T., Lévesque, L. E., Hux, J. E., Juurlink, D. N., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.298.22.2634 · Cited by 345
Poynard, T., Munteanu, M., Imbert-Bismut, F., Charlotte, F., Thabut, D., Le Calvez, S., Messous, D., Thibault, V., Benhamou, Y., Moussalli, J., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032227 · Cited by 343
Myers, R. P., Pollett, A., Kirsch, R., Pomier‐Layrargues, G., Beaton, M., Levstik, M., Duarte‐Rojo, A., Wong, D., Crotty, P., & Elkashab, M. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02781.x · Cited by 343
Lee, Y.-H., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y. J., Lee, B.-W., Kang, E. S., Han, K.-H., Lee, H. C., & Cha, B.-S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
Self-citationA randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Ratziu, V., de Ledinghen, V., Oberti, F., Mathurin, P., Wartelle-Bladou, C., Renou, C., Sogni, P., Maynard, M., Larrey, D., Serfaty, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.030 · Cited by 338
Association between non-alcoholic fatty liver disease and cancer incidence rate
Kim, G.-A., Lee, H. C., Choe, J., Kim, M.-J., Lee, M. J., Chang, H.-S., Bae, I. Y., Kim, H.-K., An, J., Shim, J. H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.012 · Cited by 331
Self-citationBrowning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007674 · Cited by 328
Simmons, O., Fetzer, D. T., Yokoo, T., Marrero, J. A., Yopp, A., Kono, Y., Parikh, N. D., Browning, T., & Singal, A. G. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13841 · Cited by 328
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
The Mediterranean Diet and Nutritional Adequacy: A Review
Castro-Quezada, I., Román-Viñas, B., & Serra-Majem, L. (2014) · Nutrients · doi:10.3390/nu6010231 · Cited by 327
Watanabe, S., Hashimoto, E., Ikejima, K., Uto, H., Ono, M., Sumida, Y., Seike, M., Takei, Y., Takehara, T., Tokushige, K., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1050-7 · Cited by 327
Ryan, C. K., Johnson, L. A., Germin, B. I., & Marcos, A. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.36740 · Cited by 326
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Merriman, R. B., Ferrell, L. D., Patti, M. G., Weston, S. R., Pabst, M. S., Aouizerat, B. E., & Bass, N. M. (2006) · Hepatology · doi:10.1002/hep.21346 · Cited by 324
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, J. W., Konopski, Z., Eggesbø, H. B., von Volkmann, H. L., Raschpichler, G., Bjøro, K., Haaland, T., Løberg, E. M., & Birkeland, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902845268 · Cited by 323
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
Younossi, Z. M., Gramlich, T., Liu, Y. C., Matteoni, C. A., Petrelli, M., Goldblum, J. R., Rybicki, L. A., & McCullough, A. J. (1998) · PubMed · Cited by 321
Habitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans
Perseghin, G., Lattuada, G., De Cobelli, F., Ragogna, F., Ntali, G., Esposito, A., Belloni, E., Canu, T., Terruzzi, I., Scifo, P., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2032 · Cited by 320
Singh, S., Singh, P. P., Singh, A. G., Murad, M. H., & Sanchez, W. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.5 · Cited by 320
Wong, V. W.-S., Wong, G. L.-H., Chan, R. S.-M., Shu, S. S.-T., Cheung, B. H.-K., Li, L. S., Chim, A. M.-L., Chan, C. K.-M., Leung, J. K.-Y., Chu, W. C.-W., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.011 · Cited by 319
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
Suzuki, A., Lindor, K., Saver, J. S., Lymp, J., Mendes, F., Muto, A., Okada, T., & Angulo, P. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.008 · Cited by 319
Yatsuji, S., Hashimoto, E., Tobari, M., Taniai, M., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05640.x · Cited by 318
Leuschner, U. F. H., Lindenthal, B., Herrmann, G., Arnold, J. C., Rössle, M., Cordes, H., Zeuzem, S., Hein, J., & Berg, T. (2010) · Hepatology · doi:10.1002/hep.23727 · Cited by 317
Thomas, E. L., Hamilton, G., Patel, N., O’Dwyer, R., Doré, C. J., Goldin, R. D., Bell, J. D., & Taylor-Robinson, S. D. (2005) · Gut · doi:10.1136/gut.2003.036566 · Cited by 317
Zelber–Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., & Oren, R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.004 · Cited by 317
Effect of aerobic exercise training dose on liver fat and visceral adiposity
Keating, S. E., Hackett, D. A., Parker, H. M., O’Connor, H. T., Gerofi, J. A., Sainsbury, A., Baker, M. K., Chuter, V. H., Caterson, I. D., George, J., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.022 · Cited by 313
Scorletti, E., Bhatia, L., McCormick, K. G., Clough, G. F., Nash, K., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310
Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Jeong, S. H., Lee, D. H., et al. (2012) · Hepatology · doi:10.1002/hep.25593 · Cited by 310
Self-citationSanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W., & Chojkier, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.046 · Cited by 309
Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism
Chung, G. E., Kim, D., Kim, W., Yim, J. Y., Park, M. J., Kim, Y. J., Yoon, J.-H., & Lee, H.-S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.027 · Cited by 305
Self-citationVali, Y., Lee, J., Boursier, J., Spijker, R., Löffler, J., Verheij, J., Brosnan, M. J., Böcskei, Z., Anstee, Q. M., Bossuyt, P. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.036 · Cited by 302
Self-citationSullivan, S., Kirk, E. P., Mittendorfer, B., Patterson, B. W., & Klein, S. (2012) · Hepatology · doi:10.1002/hep.25548 · Cited by 301
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
Chavez-Tapia, N. C., Tellez-Avila, F. I., Barrientos-Gutierrez, T., Mendez-Sanchez, N., Lizardi-Cervera, J., & Uribe, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007340.pub2 · Cited by 297
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
Loria, P., Adinolfi, L. E., Bellentani, S., Bugianesi, E., Grieco, A., Fargion, S., Gasbarrini, A., Loguercio, C., Lonardo, A., Marchesini, G., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.021 · Cited by 294
El–Serag, H. B., Johnson, M. L., Hachem, C., & Morgana, R. O. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.053 · Cited by 291
Zhang, S., Wang, J., Liu, Q., & Harnish, D. C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.025 · Cited by 290
Dunn, W., Sanyal, A. J., Brunt, E. M., Unalp-Arida, A., Donohue, M., McCullough, A. J., & Schwimmer, J. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.024 · Cited by 278
Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound
Fishbein, M., Castro, F., Cheruku, S., Jain, S., Webb, B., Gleason, T., & Stevens, W. R. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200508000-00012 · Cited by 277
Gu, J., Liu, S., Du, S., Zhang, Q., Xiao, J., Dong, Q., & Xin, Y. (2019) · European Radiology · doi:10.1007/s00330-019-06072-4 · Cited by 276
Middleton, M. S., Heba, E. R., Hooker, C. A., Bashir, M. R., Fowler, K. J., Sandrasegaran, K., Brunt, E. M., Kleiner, D. E., Doo, E., Van Natta, M. L., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.005 · Cited by 276
Cancer risk among statin users: A population‐based cohort study
Friis, S., Poulsen, A. H., Johnsen, S. P., McLaughlin, J. K., Fryzek, J. P., Dalton, S. O., Sørensen, H. T., & Olsen, J. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.20758 · Cited by 275
Kantartzis, K., Thamer, C., Peter, A., Machann, J., Schick, F., Schraml, C., Konigsrainer, A., Konigsrainer, I., Krober, S., Niess, A., et al. (2009) · Gut · doi:10.1136/gut.2008.151977 · Cited by 273
Cusi, K., Chang, Z., Harrison, S., Lomonaco, R., Bril, F., Orsak, B., Ortiz-Lopez, C., Hecht, J., Feldstein, A. E., Webb, A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.042 · Cited by 273
Lee, J. Y., Kim, K. M., Lee, S. G., Yu, E., Lim, Y.-S., Lee, H. C., Chung, Y.-H., Lee, Y. S., & Suh, D.-J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.007 · Cited by 272
Self-citationKatsagoni, C. N., Georgoulis, M., Papatheodoridis, G. V., Panagiotakos, D. B., & Kontogianni, M. D. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.006 · Cited by 270
Koutoukidis, D. A., Astbury, N. M., Tudor, K. E., Morris, E., Henry, J. A., Noreik, M., Jebb, S. A., & Aveyard, P. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2248 · Cited by 270
An Assessment of Statin Safety by Hepatologists
Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 269
Loguercio, C., Andreone, P., Brisc, C., Brisc, M. C., Bugianesi, E., Chiaramonte, M., Cursaro, C., Danila, M., de Sio, I., Floreani, A., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.008 · Cited by 267
Statins and hepatotoxicity: Focus on patients with fatty liver†
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 265
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
Loomba, R., Sirlin, C. B., Schwimmer, J. B., & Lavine, J. E. (2009) · Hepatology · doi:10.1002/hep.23119 · Cited by 264
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Toshimitsu, K., Matsuura, B., Ohkubo, I., Niiya, T., Furukawa, S., Hiasa, Y., Kawamura, M., Ebihara, K., & Onji, M. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.004 · Cited by 264
Obstructive Sleep Apnea, Hypoxia, and Nonalcoholic Fatty Liver Disease
Mesarwi, O. A., Loomba, R., & Malhotra, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1109tr · Cited by 263
Comparison of blood tests for liver fibrosis specific or not to NAFLD
Calès, P., Lainé, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F., Hunault, G., Rousselet, M. C., Hubert, I., Laafi, J., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.035 · Cited by 260
Vuppalanchi, R., Siddiqui, M. S., Van Natta, M. L., Hallinan, E., Brandman, D., Kowdley, K., Neuschwander‐Tetri, B. A., Loomba, R., Dasarathy, S., Abdelmalek, M., et al. (2018) · Hepatology · doi:10.1002/hep.29489 · Cited by 260
Fakhry, T. K., Mhaskar, R., Schwitalla, T., Muradova, E., Gonzalvo, J. P., & Murr, M. M. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.12.002 · Cited by 259 · cited 1×
“Recent meta-analyses identified that bariatric surgery effectively reduced the amount of fat in the liver, inflammation, and fibrosis in NASH patients.(353,354) However, histological worsening after surgery was observed in some patients.”
BackgroundPetrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0007-z · Cited by 257
Bower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 256
Laish, I., Braun, M., Mor, E., Sulkes, J., Harif, Y., & Ari, Z. B. (2011) · Liver Transplantation · doi:10.1002/lt.22198 · Cited by 256
Nobili, V., Bedogni, G., Alisi, A., Pietrobattista, A., Rise, P., Galli, C., & Agostoni, C. (2011) · Archives of Disease in Childhood · doi:10.1136/adc.2010.192401 · Cited by 256
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
Lee, Y.-C. A., Cohet, C., Yang, Y.-C., Stayner, L., Hashibe, M., & Straif, K. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp280 · Cited by 254
van der Heijden, G., Wang, Z. J., Chu, Z. D., Sauer, P. J. J., Haymond, M. W., Rodriguez, L. M., & Sunehag, A. L. (2010) · Obesity · doi:10.1038/oby.2009.274 · Cited by 253
Singh, S., Venkatesh, S. K., Loomba, R., Wang, Z., Sirlin, C., Chen, J., Yin, M., Miller, F. H., Low, R. N., Hassanein, T., et al. (2016) · European Radiology · doi:10.1007/s00330-015-3949-z · Cited by 252
Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction
Adams, L. A., Feldstein, A., Lindor, K. D., & Angulo, P. (2004) · Hepatology · doi:10.1002/hep.20140 · Cited by 252
Kramer, H., Pickhardt, P. J., Kliewer, M. A., Hernando, D., Chen, G.-H., Zagzebski, J. A., & Reeder, S. B. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.16565 · Cited by 252
Lewis, J. H., Mortensen, M. E., Zweig, S., Fusco, M. J., Medoff, J. R., & Belder, R. (2007) · Hepatology · doi:10.1002/hep.21848 · Cited by 248
A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects
Lee, J. M., Lee, Y. K., Mamrosh, J. L., Busby, S. A., Griffin, P. R., Pathak, M. C., Ortlund, E. A., & Moore, D. D. (2011) · Nature · doi:10.1038/nature10111 · Cited by 247
Self-citationClinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis
Patton, H. M., Lavine, J. E., Van Natta, M. L., Schwimmer, J. B., Kleiner, D., & Molleston, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.050 · Cited by 243
Gepner, Y., Shelef, I., Komy, O., Cohen, N., Schwarzfuchs, D., Bril, N., Rein, M., Serfaty, D., Kenigsbuch, S., Zelicha, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.013 · Cited by 236
Slentz, C. A., Bateman, L. A., Willis, L. H., Shields, A. T., Tanner, C. J., Piner, L. W., Hawk, V. H., Muehlbauer, M. J., Samsa, G. P., Nelson, R. C., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2011 · Cited by 235
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., Sorgato, C., Zenari, L., & Bonora, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.030 · Cited by 235
Antioxidant supplements and mortality
Bjelakovic, G., Nikolova, D., & Gluud, C. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000009 · Cited by 234
A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234
Targher, G., Bertolini, L., Rodella, S., Lippi, G., Zoppini, G., & Chonchol, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05050610 · Cited by 233
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., & Ehman, R. L. (2013) · Radiology · doi:10.1148/radiol.13121193 · Cited by 231
Self-citationNonalcoholic fatty liver disease in women with polycystic ovary syndrome
Paschou, S. A., Polyzos, S. A., Anagnostis, P., Goulis, D. G., Kanaka-Gantenbein, C., Lambrinoudaki, I., Georgopoulos, N. A., & Vryonidou, A. (2020) · Endocrine · doi:10.1007/s12020-019-02085-7 · Cited by 231
Nelson, A., Torres, D. M., Morgan, A. E., Fincke, C., & Harrison, S. A. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31819c392e · Cited by 230
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu020 · Cited by 229
Chang, Y., Ryu, S., Sung, E., & Jang, Y. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081257 · Cited by 229
Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
Browning, J. D., Kumar, K. S., Saboorian, M. H., & Thiele, D. L. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04059.x · Cited by 227
Properzi, C., O'Sullivan, T. A., Sherriff, J. L., Ching, H. L., Jeffrey, G. P., Buckley, R. F., Tibballs, J., MacQuillan, G. C., Garas, G., & Adams, L. A. (2018) · Hepatology · doi:10.1002/hep.30076 · Cited by 227
Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial†
Abdelmalek, M. F., Sanderson, S. O., Angulo, P., Soldevila‐Pico, C., Liu, C., Peter, J., Keach, J., Cave, M., Chen, T., McClain, C. J., et al. (2009) · Hepatology · doi:10.1002/hep.23239 · Cited by 225
Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
Paik, J. M., Henry, L., De Avila, L., Younossi, E., Racila, A., & Younossi, Z. M. (2019) · Hepatology Communications · doi:10.1002/hep4.1419 · Cited by 225
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Lee, D.-H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl086 · Cited by 224
Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery
Barker, K. B., Palekar, N. A., Bowers, S. P., Goldberg, J. E., Pulcini, J. P., & Harrison, S. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00419.x · Cited by 218
Is Liver Biopsy Useful in the Evaluation of Patients with Chronically Elevated Liver Enzymes?
Van Ness, M. M., & Diehl, A. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-473 · Cited by 213
CKD and Nonalcoholic Fatty Liver Disease
Targher, G., Chonchol, M. B., & Byrne, C. D. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.05.019 · Cited by 213
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Dunn, W., Xu, R., & Schwimmer, J. B. (2008) · Hepatology · doi:10.1002/hep.22292 · Cited by 213
Cassidy, S., Thoma, C., Hallsworth, K., Parikh, J., Hollingsworth, K. G., Taylor, R., Jakovljevic, D. G., & Trenell, M. I. (2016) · Diabetologia · doi:10.1007/s00125-015-3741-2 · Cited by 212
Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions
Srinivasa Babu, A., Wells, M. L., Teytelboym, O. M., Mackey, J. E., Miller, F. H., Yeh, B. M., Ehman, R. L., & Venkatesh, S. K. (2016) · RadioGraphics · doi:10.1148/rg.2016160042 · Cited by 212
Houghton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A. D., Tiniakos, D., Hollingsworth, K. G., Taylor, R., Day, C. P., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.031 · Cited by 209 · cited 1×
“Aerobic exercise was mainly recommended at moderate or vigorous intensity (greater than 50–70% of maximal heart rate), and exercise for 30–60 minutes more than three times per week for at least 6 weeks was found to be effective.(258,262,266,267) Resistance exercise was recommended at 50–70% of maximal strength (1-repe…”
BackgroundShojaee-Moradie, F., Baynes, K. C. R., Pentecost, C., Bell, J. D., Thomas, E. L., Jackson, N. C., Stolinski, M., Whyte, M., Lovell, D., Bowes, S. B., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0498-7 · Cited by 209
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
Fracanzani, A. L., Burdick, L., Raselli, S., Pedotti, P., Grigore, L., Santorelli, G., Valenti, L., Maraschi, A., Catapano, A., & Fargion, S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.08.041 · Cited by 209
Relationship of sitting time and physical activity with non-alcoholic fatty liver disease
Ryu, S., Chang, Y., Jung, H.-S., Yun, K. E., Kwon, M.-J., Choi, Y., Kim, C.-W., Cho, J., Suh, B.-S., Cho, Y. K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.010 · Cited by 209
Self-citationMetabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
Chang, Y., Jung, H.-S., Cho, J., Zhang, Y., Yun, K. E., Lazo, M., Pastor-Barriuso, R., Ahn, J., Kim, C.-W., Rampal, S., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.178 · Cited by 209
Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., Mathiesen, U. L., Bodemar, G., Ekstedt, M., Franzén, L. E., Holmqvist, M., Bendtsen, P., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802555991 · Cited by 208
Weight change and obesity after liver transplantation: Incidence and risk factors
Everhart, J. E., Lombardero, M., Lake, J. R., Wiesner, R. H., Zetterman, R. K., & Hoofnagle, J. H. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040402 · Cited by 207
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206
Krawczyk, M., Rau, M., Schattenberg, J. M., Bantel, H., Pathil, A., Demir, M., Kluwe, J., Boettler, T., Lammert, F., & Geier, A. (2017) · Journal of Lipid Research · doi:10.1194/jlr.p067454 · Cited by 204
Wang, X., Li, J., Riaz, D. R., Shi, G., Liu, C., & Dai, Y. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.023 · Cited by 200
Bril, F., Kalavalapalli, S., Clark, V. C., Lomonaco, R., Soldevila-Pico, C., Liu, I.-C., Orsak, B., Tio, F., & Cusi, K. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.12.001 · Cited by 199
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., Hyogo, H., Yamaguchi, K., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Imai, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0305-6 · Cited by 199
Kim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198 · cited 1×
“1 cases per 1,000 persons.(12) According to a meta-analysis in Asia, the annual incidence rate in Korea was 45.”
BackgroundSatapathy, S. K., Garg, S., Chauhan, R., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40220.x · Cited by 198
Chronological development of elevated aminotransferases in a nonalcoholic population
Suzuki, A., Angulo, P., Lymp, J., St. Sauver, J., Muto, A., Okada, T., & Lindor, K. (2005) · Hepatology · doi:10.1002/hep.20543 · Cited by 197
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Park, H., Shima, T., Yamaguchi, K., Mitsuyoshi, H., Minami, M., Yasui, K., Itoh, Y., Yoshikawa, T., Fukui, M., Hasegawa, G., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0291-8 · Cited by 195
Pickhardt, P. J., Park, S. H., Hahn, L., Lee, S.-G., Bae, K. T., & Yu, E. S. (2012) · European Radiology · doi:10.1007/s00330-011-2349-2 · Cited by 194
Pu, K., Wang, Y., Bai, S., Wei, H., Zhou, Y., Fan, J., & Qiao, L. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0961-9 · Cited by 194
Vilar‐Gomez, E., Vuppalanchi, R., Gawrieh, S., Ghabril, M., Saxena, R., Cummings, O. W., & Chalasani, N. (2020) · Hepatology · doi:10.1002/hep.30368 · Cited by 193
A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
Harrison, S. A., Fincke, C., Helinski, D., Torgerson, S., & Hayashi, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02153.x · Cited by 191
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
GÓMEZ‐DOMÍNGUEZ, E., GISBERT, J. P., MORENO‐MONTEAGUDO, J. A., GARCÍA‐BUEY, L., & MORENO‐OTERO, R. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02926.x · Cited by 189
An assessment by the Statin Liver Safety Task Force: 2014 update
Bays, H., Cohen, D. E., Chalasani, N., & Harrison, S. A. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.02.011 · Cited by 187
Zhu, F.-S., Liu, S., Chen, X.-M., Huang, Z.-G., & Zhang, D.-W. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6395 · Cited by 187
Final results of a long-term, clinical follow-up in fatty liver patients
Dam-Larsen, S., Becker, U., Franzmann, M.-B., Larsen, K., Christoffersen, P., & Bendtsen, F. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520903171284 · Cited by 187
Park, H. S., Han, J. H., Choi, K. M., & Kim, S. M. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1046 · Cited by 185
Self-citationTorres, D. M., Jones, F. J., Shaw, J. C., Williams, C. D., Ward, J. A., & Harrison, S. A. (2011) · Hepatology · doi:10.1002/hep.24558 · Cited by 183
Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
Roberts, E. A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.003 · Cited by 181
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 180
Chan, W., Nik Mustapha, N. R., & Mahadeva, S. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12557 · Cited by 180
Poynard, T., Munteanu, M., Luckina, E., Perazzo, H., Ngo, Y., Royer, L., Fedchuk, L., Sattonnet, F., Pais, R., Lebray, P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.021 · Cited by 179
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD
Tapper, E. B., & Loomba, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.10 · Cited by 179
Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease
Kim, D., Chung, G. E., Kwak, M.-S., Seo, H. B., Kang, J. H., Kim, W., Kim, Y. J., Yoon, J.-H., Lee, H.-S., & Kim, C. Y. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.024 · Cited by 174
Self-citationPentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
Van Wagner, L. B., Koppe, S. W. P., Brunt, E. M., Gottstein, J., Gardikiotes, K., Green, R. M., & Rinella, M. E. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31539-x · Cited by 173
Bairati, I., Meyer, F., Jobin, E., Gélinas, M., Fortin, A., Nabid, A., Brochet, F., & Têtu, B. (2006) · International Journal of Cancer · doi:10.1002/ijc.22042 · Cited by 171
Bril, F., Sninsky, J. J., Baca, A. M., Superko, H. R., Portillo Sanchez, P., Biernacki, D., Maximos, M., Lomonaco, R., Orsak, B., Suman, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3111 · Cited by 168
Chon, Y. E., Jung, K. S., Kim, S. U., Park, J. Y., Park, Y. N., Kim, D. Y., Ahn, S. H., Chon, C. Y., Lee, H. W., Park, Y., et al. (2014) · Liver International · doi:10.1111/liv.12282 · Cited by 167
Self-citationMohamad, B., Shah, V., Onyshchenko, M., Elshamy, M., Aucejo, F., Lopez, R., Hanouneh, I. A., Alhaddad, R., & Alkhouri, N. (2016) · Hepatology International · doi:10.1007/s12072-015-9679-0 · Cited by 166
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
Caussy, C., Soni, M., Cui, J., Bettencourt, R., Schork, N., Chen, C.-H., Ikhwan, M. A., Bassirian, S., Cepin, S., Gonzalez, M. P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93465 · Cited by 166
Mahady, S. E., Webster, A. C., Walker, S., Sanyal, A., & George, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.016 · Cited by 165
Sinn, D. H., Kang, D., Jang, H. R., Gu, S., Cho, S. J., Paik, S. W., Ryu, S., Chang, Y., Lazo, M., Guallar, E., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.024 · Cited by 165
Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., et al. (2012) · Hepatology · doi:10.1002/hep.24747 · Cited by 164
Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Oh, E., Cha, K., Jung, E., & Kim, W. S. (2008) · Metabolism · doi:10.1016/j.metabol.2007.11.022 · Cited by 164
Self-citationAntioxidants are not identical and their effects are not uniform over the population (2009)
Hemilä, H. (2009) · doi:10.13140/2.1.4426.0641 · Cited by 164
Singh, S., Khera, R., Allen, A. M., Murad, M. H., & Loomba, R. (2015) · Hepatology · doi:10.1002/hep.27999 · Cited by 163
Chang, Y., Jung, H.-S., Yun, K. E., Cho, J., Cho, Y. K., & Ryu, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.349 · Cited by 163
Self-citationSinn, D. H., Kang, D., Chang, Y., Ryu, S., Gu, S., Kim, H., Seong, D., Cho, S. J., Yi, B.-K., Park, H.-D., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311854 · Cited by 163
Self-citationThe efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
Pastori, D., Polimeni, L., Baratta, F., Pani, A., Del Ben, M., & Angelico, F. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.07.170 · Cited by 162
Chang, Y., Cho, Y. K., Kim, Y., Sung, E., Ahn, J., Jung, H., Yun, K. E., Shin, H., & Ryu, S. (2019) · Hepatology · doi:10.1002/hep.30170 · Cited by 162
Self-citationGuo, Z., Li, M., Han, B., & Qi, X. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.08.012 · Cited by 162
Simon, T. G., King, L. Y., Chong, D. Q., Nguyen, L. H., Ma, Y., VoPham, T., Giovannucci, E. L., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., et al. (2018) · Hepatology · doi:10.1002/hep.29660 · Cited by 160
Zein, C. O., Lopez, R., Fu, X., Kirwan, J. P., Yerian, L. M., McCullough, A. J., Hazen, S. L., & Feldstein, A. E. (2012) · Hepatology · doi:10.1002/hep.25778 · Cited by 160
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study
Jung, H. S., Chang, Y., Kwon, M., Sung, E., Yun, K. E., Cho, Y. K., Shin, H. C., & Ryu, S. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0283-5 · Cited by 160
Self-citationBaranova, A. V., Tran, T., Birerdinc, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04579.x · Cited by 158
Bae, J. S., Lee, D. H., Lee, J. Y., Kim, H., Yu, S. J., Lee, J., Cho, E. J., Lee, Y. B., Han, J. K., & Choi, B. I. (2019) · European Radiology · doi:10.1007/s00330-019-06272-y · Cited by 158
Self-citationEffect of exercise on the development of new fatty liver and the resolution of existing fatty liver
Sung, K., Ryu, S., Lee, J., Kim, J., Wild, S. H., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.026 · Cited by 156
Self-citationLee, S. B., Park, G., Lee, J., Lee, B. U., Park, J. H., Kim, B. G., Jung, S. W., Jeong, I. D., Bang, S. J., Shin, J. W., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.12.012 · Cited by 155
Self-citationBrunt, E. M., Kleiner, D. E., Wilson, L. A., Sanyal, A. J., Neuschwander‐Tetri, B. A., & for the Nonalcoholic Steatohepatitis Clinical Research Network (2019) · Hepatology · doi:10.1002/hep.30418 · Cited by 154 · cited 1×
“Fibrosis progresses more rapidly in patients with steatohepatitis than in those without it,(36,38) and changes in steatohepatitis are associated with the progression of fibrosis.(229,230) Therefore, patients with hepatic fibrosis or steatohepatitis can receive pharmacologic treatment to improve their long-term prognos…”
BackgroundPrognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children
Wang, C., Liang, L., Fu, J., Zou, C., Hong, F., Xue, J.-Z., Lu, J.-R., & Wu, X.-M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1598 · Cited by 149
Kenneally, S., Sier, J. H., & Moore, J. B. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000139 · Cited by 145
Yang, W.-S., Va, P., Bray, F., Gao, S., Gao, J., Li, H. L., & Xiang, Y.-B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027326 · Cited by 144
Riley, M. R., Bass, N. M., Rosenthal, P. J., & Merriman, R. B. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.07.020 · Cited by 144
Doycheva, I., Issa, D., Watt, K. D. S., López, R., Rifai, G., & Alkhouri, N. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000925 · Cited by 143
Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: An open‐label, pilot study
Yoneda, M., Fujita, K., Nozaki, Y., Endo, H., Takahashi, H., Hosono, K., Suzuki, K., Mawatari, H., Kirikoshi, H., Inamori, M., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00644.x · Cited by 142
Imajo, K., Honda, Y., Kobayashi, T., Nagai, K., Ozaki, A., Iwaki, M., Kessoku, T., Ogawa, Y., Takahashi, H., Saigusa, Y., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.12.016 · Cited by 140
Results of Laparoscopic Gastric Bypass in Patients with Cirrhosis
Dallal, R. M., Mattar, S. G., Lord, J. L., Watson, A. R., Cottam, D. R., Eid, G. M., Hamad, G. G., Rabinovitz, M., & Schauer, P. R. (2004) · Obesity Surgery · doi:10.1381/096089204772787284 · Cited by 140
Wu, K., Kuo, P., Su, S., Chen, Y., Yeh, M.-L., Huang, C., Yang, J., Lin, C.-I., Hsieh, M., Hsieh, M., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.026 · Cited by 140
The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
Miller, C. M., Quintini, C., Dhawan, A. K., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000001571 · Cited by 140
Noureddin, M., Jones, C., Alkhouri, N., Gomez, E. V., Dieterich, D. T., Rinella, M. E., Therapondos, G., Girgrah, N., Mantry, P. S., Sussman, N. L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.050 · Cited by 140
Trout, A. T., Serai, S. D., Mahley, A. D., et al. (2016) · Radiology · doi:10.1148/radiol.2016160209 · Cited by 134
Shire, N. J., Yin, M., Chen, J., Railkar, R. A., Fox‐Bosetti, S., Johnson, S. M., Beals, C. R., Dardzinski, B. J., Sanderson, S. O., Talwalkar, J. A., et al. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22716 · Cited by 133
Poggio, P. D., Olmi, S., Ciccarese, F., Marco, M. D., Rapaccini, G. L., Benvegnù, L., Borzio, F., Farinati, F., Zoli, M., Giannini, E. G., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.02.025 · Cited by 133
Clinical utilization of shear wave dispersion imaging in diffuse liver disease
Sugimoto, K., Moriyasu, F., Oshiro, H., Takeuchi, H., Yoshimasu, Y., Kasai, Y., & Itoi, T. (2019) · ULTRASONOGRAPHY · doi:10.14366/usg.19031 · Cited by 132
Kim, J. H., Kwon, S. Y., Lee, S. W., & Lee, C. H. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02580.x · Cited by 131
Sinn, D. H., Gwak, G., Park, H. N., Kim, J. E., Min, Y. W., Kim, K. M., Kim, Y. J., Choi, M. S., Lee, J. H., Koh, K. C., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.400 · Cited by 131
Self-citationHistologic Variation of Grade and Stage of Non-alcoholic Fatty Liver Disease in Liver Biopsies
Janiec, D. J., Jacobson, E. R., Freeth, A., Spaulding, L., & Blaszyk, H. (2005) · Obesity Surgery · doi:10.1381/0960892053723268 · Cited by 131
Update on non-alcoholic fatty liver disease in children
Papandreou, D., Rousso, I., & Mavromichalis, I. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.02.002 · Cited by 131
A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis
Jan, A., Narwaria, M., & Mahawar, K. K. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1727-2 · Cited by 129
Bae, J. C., Cho, Y. K., Lee, W., Seo, H. I., Rhee, E., Park, S. E., Park, C., Oh, K. W., Sung, K., & Kim, B. I. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.275 · Cited by 129
Self-citationSerum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men
Ryu, S., Chang, Y., Kim, S. G., Cho, J., & Güallar, E. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.005 · Cited by 129
Self-citationIdılman, R., Mızrak, D., CORAPCIOGLU, D., Bektaş, M., Doğanay, B., Saykı, M., Çoban, Ş., Erden, E., Soykan, İ., Emral, R., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03723.x · Cited by 128
Sung, K., Ryan, M. C., & Wilson, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.024 · Cited by 128
Bariatric surgery in patients with liver cirrhosis
Shimizu, H., Phuong, V., Maia, M., Kroh, M., Chand, B., Schauer, P. R., & Brethauer, S. A. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.07.021 · Cited by 128
Choi, S.-Y., Kim, D., Kim, H. J., Kang, J. H., Chung, S. J., Park, M. J., Kim, Y. S., Kim, C. H., Choi, S. H., Kim, W. K., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.238 · Cited by 127
Self-citationGastrointestinal and Nutritional Complications After Bariatric Surgery.
Decker, G. A., Swain, J. M., Crowell, M. D., & Scolapio, J. S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01421.x · Cited by 127
Shamsoddini, A., Sobhani, V., Ghamar Chehreh, M. E., Alavian, S. M., & Zaree, A. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.31434 · Cited by 126 · cited 3×
“Resistance exercise was recommended at 50–70% of maximal strength (1-repetition maximum) for 30–60 minutes more than three times per week.(257,266,267) According to the World Health Organization and United States Department of Health and Human Services, moderate-intensity physical activities include brisk walking, dan…”
BackgroundWong, V. W., Wong, G. L., Chim, A. M., Tse, A. M. L., Tsang, S. W., Hui, A., Choi, P. C., Chan, A. W. H., So, W., Chan, F. K. L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01933.x · Cited by 126
Yamada, T., Fukatsu, M., Suzuki, S., Wada, T., Yoshida, T., & Joh, T. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05998.x · Cited by 126
Ruffillo, G., Fassio, E., Álvarez, E., Landeira, G., Longo, C., Domínguez, N., & Gualano, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.028 · Cited by 126
Lee, J. I., Lee, H. W., Lee, K. S., Lee, H. S., & Park, J.-Y. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000845 · Cited by 126
Self-citationScorletti, E., West, A. L., Bhatia, L. S., Hoile, S. P., McCormick, K. G., Burdge, G. C., Lillycrop, K. A., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.036 · Cited by 124
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
Omer, Z., Çetinkalp, Ş., Akyıldız, M., Yılmaz, F., Batur, Y., Yılmaz, C., & Akarca, U. S. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832e2baf · Cited by 124
Cited by
Global Incidence and Prevalence of Nonalcoholic Fatty Liver Disease
Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0365 · Cited by 727
Chun, H. S., Lee, M., Lee, H. A., Oh, S. Y., Baek, H. J., Moon, J. W., Kim, Y. J., Lee, J., Kim, H., Kim, H. Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.043 · Cited by 60
Self-citationIvancovsky Wajcman, D., Byrne, C. J., Dillon, J. F., Brennan, P. N., Villota-Rivas, M., Younossi, Z. M., Allen, A. M., Crespo, J., Gerber, L. H., & Lazarus, J. V. (2026) · Hepatology · doi:10.1097/hep.0000000000001058 · Cited by 33
Lee, H. A., Moon, H., Kim, Y., Lee, J. K., Lee, H. A., & Kim, H. Y. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.051 · Cited by 9
Self-citation
Metadata
- Authors
- Kang, S. H., Lee, H. W., Yoo, J.-J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., Jun, D. W., Choi, J.-I., Song, D. S., Kim, W., Jeong, S. W., Kim, M. Y., Koh, H., Jeong, S., Lee, J.-W., Cho, Y. K., & The Korean Association for the Study of the Liver (KASL)
- Venue
- Clinical and Molecular Hepatology
- Published
- 2021-07-01
- Volume
- 27
- Issue
- 3
- Pages
- 363-401
- ISSN
- 2287-2728 (ISSN-L)
- 2287-285X
- OpenAlex
- W3175482227
- Cited by
- 267
- References
- 535
- FWCI
- 31.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.